The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Mar. 23, 2015
Applicants:

Virender Singh Aulakh, Whitehorse, CA;

Anthony Casarez, San Francisco, CA (US);

Xiaodong Lin, Orinda, CA (US);

Mika Lindvall, Oakland, CA (US);

Glenn Mcenroe, San Mateo, CA (US);

Heinz Ernst Moser, San Mateo, CA (US);

Folkert Reck, San Mateo, CA (US);

Meiliana Tjandra, Walnut Creek, CA (US);

Robert Lowell Simmons, San Francisco, CA (US);

Aregahegn Yifru, Pleasant Hill, CA (US);

Qingming Zhu, Walnut Creek, CA (US);

Inventors:

Virender Singh Aulakh, Whitehorse, CA;

Anthony Casarez, San Francisco, CA (US);

Xiaodong Lin, Orinda, CA (US);

Mika Lindvall, Oakland, CA (US);

Glenn McEnroe, San Mateo, CA (US);

Heinz Ernst Moser, San Mateo, CA (US);

Folkert Reck, San Mateo, CA (US);

Meiliana Tjandra, Walnut Creek, CA (US);

Robert Lowell Simmons, San Francisco, CA (US);

Aregahegn Yifru, Pleasant Hill, CA (US);

Qingming Zhu, Walnut Creek, CA (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/40 (2006.01); C07D 417/14 (2006.01); A61K 31/427 (2006.01); A61K 31/454 (2006.01); A61K 31/4439 (2006.01); A61K 31/433 (2006.01); A61K 31/496 (2006.01); A61K 31/4545 (2006.01); C07D 487/04 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 31/427 (2013.01); A61K 31/433 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/4545 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01); C07D 487/04 (2013.01);
Abstract

This invention pertains generally to antibacterial compounds of Formula I, as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria.


Find Patent Forward Citations

Loading…